Citation: | SHEN Yuan-juan, DAI Zheng-xiang, LI Ju-yun, WU Xiao-yu, WANG Sai-nan, WANG Qing. Incidence and influencing factors of high-output ileostomy in adults: a meta-analysis[J]. Chinese Journal of General Practice, 2023, 21(2): 324-328. doi: 10.16766/j.cnki.issn.1674-4152.002874 |
[1] |
FIELDING A, WOODS R, MOOSVI S R, et al. Renal impairment after ileostomy formation: a frequent event with long-term consequences[J]. Colorectal Dis, 2020, 22(3): 269-278. doi: 10.1111/codi.14866
|
[2] |
LORIA A, MELUCCI A, SPERANZA J, et al. Acute kidney injury is a common and significant complication following ileostomy formation[J]. Colorectal Dis, 2022, 24(1): 102-110. doi: 10.1111/codi.15917
|
[3] |
LEE N, LEE S Y, KIM C H, et al. The relationship between high-output stomas, postoperative ileus, and readmission after rectal cancer surgery with diverting ileostomy[J]. Ann Coloproctol, 2021, 37(1): 44-50. doi: 10.3393/ac.2020.08.03
|
[4] |
涂瑞沙, 蔡耀庆, 郝云鹤, 等. 加速康复外科模式下直肠癌切除术后1个月内再入院预测因素[J]. 中国老年学杂志, 2021, 41(13): 2724-2727. doi: 10.3969/j.issn.1005-9202.2021.13.012
TU R S, CAI Y Q, HAO Y H, et al. Predictors of readmission within 1 month after rectal cancer resection in the accelerated rehabilitation surgical model[J]. Chinese Journal of Gerontology, 2021, 41(13): 2724-2727. doi: 10.3969/j.issn.1005-9202.2021.13.012
|
[5] |
JUSTINIANO C F, TEMPLE L K, SWANGER A A, et al. Readmissions with dehydration after ileostomy creation: rethinking risk factors[J]. Dis Colon Rectum, 2018, 61(11): 1297-1305. doi: 10.1097/DCR.0000000000001137
|
[6] |
艾飞玲, 胡葵茹, 石钰霖, 等. 基于纽卡斯尔-渥太华量表对中国吸烟队列研究文献的质量评价[J]. 中华疾病控制杂志, 2021, 25(6): 722-729. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202106018.htm
AI F L, HU K R, SHI Y L, et al. Quality assessment of cohort studies literature on Chinese smoking by using Newcastle-Ottawa-Scale[J]. Chinese Journal of Disease Control & Prevention, 2021, 25(6): 722-729. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202106018.htm
|
[7] |
ASSAF D, HAZZAN D, BEN-YAACOV A, et al. Predisposing factors for high output stoma in patients with a diverting loop ileostomy after colorectal surgeries[J]. Ann Coloproctol, 2021. DOI: 10.3393/ac.2021.00241.0034.
|
[8] |
BAI D X, LI L, SHEN Z L, et al. Risk factors for developing high-output ileostomy in CRC patients: a retrospective study[J]. BMC Surg, 2021, 21(1): 300. doi: 10.1186/s12893-021-01288-y
|
[9] |
HARA Y, MIURA T, SAKAMOTO Y, et al. Organ/space infection is a common cause of high output stoma and outlet obstruction in diverting ileostomy[J]. BMC Surg, 2020, 20(1): 83. doi: 10.1186/s12893-020-00734-7
|
[10] |
NAKANISHI R, KONISHI T, NAKAYA E, et al. Predisposing factors and clinical impact of high-output syndrome after sphincter-preserving surgery with covering ileostomy for rectal cancer: a retrospective single-center cohort study[J]. Int J Clin Oncol, 2021, 26(1): 118-125. doi: 10.1007/s10147-020-01781-z
|
[11] |
PAK J, UEMURA M, FUKUDA Y, et al. Predictors of high-output stoma after low anterior resection with diverting ileostomy for rectal cancer[J]. Int Surg, 2017, 102(7-8): 313-317. doi: 10.9738/INTSURG-D-17-00121.1
|
[12] |
SEIFARTH C, AUGUSTIN L N, LEHMANN K S, et al. Assessment of risk factors for the occurrence of a high-output ileostomy[J]. Front Surg, 2021, 8: 642288. DOI: 10.3389/fsurg.2021.642288.
|
[13] |
TAKEDA M, TAKAHASHI H, HARAGUCHI N, et al. Factors predictive of high-output ileostomy: a retrospective single-center comparative study[J]. Surg Today, 2019, 49(6): 482-487. doi: 10.1007/s00595-018-1756-2
|
[14] |
VERGARA-FERNÁNDEZ O, TREJO-AVILA M, SANTES O, et al. Predictors of dehydration and acute renal failure in patients with diverting loop ileostomy creation after colorectal surgery[J]. World J Clin Cases, 2019, 7(14): 1805-1813. doi: 10.12998/wjcc.v7.i14.1805
|
[15] |
CHUN L J, HAIGH P I, TAM M S, et al. Defunctioning loop ileostomy for pelvic anastomoses: predictors of morbidity and nonclosure[J]. Dis Colon Rectum, 2012, 55(2): 167-174. doi: 10.1097/DCR.0b013e31823a9761
|
[16] |
URIBE A A, WEAVER T E, ECHEVERRIA-VILLALOBOS M, et al. Perioperative morbidity and complications in patients with an established ileostomy undergoing major abdominal surgery: a retrospective study[J]. Front Surg, 2021, 8: 757269. DOI: 10.3389/fsurg.2021.757269.
|
[17] |
中华医学会外科学分会结直肠外科学组, 中国医师协会肛肠医师分会炎症性肠病专业委员会. 中国溃疡性结肠炎外科治疗指南[J]. 中华炎性肠病杂志, 2022, 6(1): 7-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWCW200604037.htm
Colorectal Surgery Group of Chinese Society of Surgery of Chinese Medical Association, Inflammatory Bowel Disease Committee of Anorectal Doctor Branch of Chinese Medical Doctor Association. Guidelines for surgical treatment of ulcerative colitis in China[J]. 中华炎性肠病杂志, 2022, 6(1): 7-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWCW200604037.htm
|
[18] |
BAKER M L, WILLIAMS R N, NIGHTINGALE J M. Causes and management of a high-output stoma[J]. Colorectal Dis, 2011, 13(2): 191-197. doi: 10.1111/j.1463-1318.2009.02107.x
|
[19] |
陈影, 程帆. 造口高排量监测及风险评估研究进展[J]. 护理研究, 2022, 36(13): 2353-2355. https://www.cnki.com.cn/Article/CJFDTOTAL-SXHZ202213017.htm
CHEN Y, CHENG F. Research progress on monitoring and risk assessment of high-output stoma[J]. Chinese Nursing Research, 2022, 36(13): 2353-2355. https://www.cnki.com.cn/Article/CJFDTOTAL-SXHZ202213017.htm
|
[20] |
FUJINO S, MIYOSHI N, OHUE M, et al. Prediction model and treatment of high-output ileostomy in colorectal cancer surgery[J]. Mol Clin Oncol, 2017, 7(3): 468-472. doi: 10.3892/mco.2017.1336
|
[21] |
黄慧峰, 张艳, 陈文晓, 等. 免疫抑制剂联合生物制剂对炎症性肠病患者营养状况及炎症因子的影响[J]. 中华全科医学, 2019, 17(5): 862-864. doi: 10.16766/j.cnki.issn.1674-4152.000811
HUANG H F, ZHANG Y, CHEN W X, et al. Effects of biologics combined with immunosuppressive agents on nutritional status and inflammatory response in patients with inflammatory bowel disease[J]. Chinese Journal of General Practice, 2019, 17(5): 862-864. doi: 10.16766/j.cnki.issn.1674-4152.000811
|
[22] |
汤阿毛, 宁丽, 楼立兰, 等. 炎症性肠病个案管理师工作职责指标体系的构建[J]. 中华全科医学, 2021, 19(10): 1775-1779. doi: 10.16766/j.cnki.issn.1674-4152.002165
TANG A M, NING L, LOU L L, et al. Construction of a responsibility index system of case managers for inflammatory bowel disease[J]. Chinese Journal of General Practice, 2021, 19(10): 1775-1779. doi: 10.16766/j.cnki.issn.1674-4152.002165
|
[23] |
MODI S, SYED GAGGATUR N, SANGE A H, et al. An emerging facet of diabetes mellitus: the nexus of gastrointestinal disorders[J]. Cureus, 2021, 13(9): e18245. DOI: 10.7759/cureus.18245.
|
[24] |
PATEL K, HORAK H, TIRYAKI E. Diabetic neuropathies[J]. Muscle Nerve, 2021, 63(1): 22-30.
|
[25] |
FENG X, LI X Q. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis[J]. Aging (Albany NY), 2022, 14(2): 975-988.
|
[26] |
桑苗苗, 吴同智, 孙子林. 糖尿病相关消化道症状的发病机制和临床诊疗进展[J]. 中华糖尿病杂志, 2021, 13(5): 513-516.
SANG M M, WU T Z, SUN Z L. Pathogenesis and clinical management of diabetes-related gastrointestinal symptoms[J]. Chinese Journal of Diabetes Mellitus, 2021, 13(5): 513-516.
|
[27] |
TAKAHASHI J, TSUJINAKA S, MAEMOTO R, et al. Tolerability and adverse events of adjuvant chemotherapy for rectal cancer in patients with diverting ileostomy[J]. In Vivo, 2020, 34(6): 3399-3406.
|
[28] |
GARCZYK A, KALICIAK I, DROGOWSKI K, et al. Influence of probiotics in prevention and treatment of patients who undergo chemotherapy or/and radiotherapy and suffer from mucositis, diarrhoea, constipation, nausea and vomiting[J]. J Clin Med, 2022, 11(12): 3412. DOI: 10.3390/jcm11123412.
|
[29] |
FENG J, GAO M, ZHAO C C, et al. Oral administration of probiotics reduces chemotherapy-induced diarrhea and oral mucositis: a systematic review and meta-analysis[J]. Front Nutr, 2022, 9: 823288. DOI: 10.3389/fnut.2022.823288.
|
[30] |
SASAKI S, NAGASAKI T, OBA K, et al. Risk factors for outlet obstruction after laparoscopic surgery and diverting ileostomy for rectal cancer[J]. Surg Today, 2021, 51(3): 366-373.
|